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E-mail address: 2005fyuan@sina.com (M. Qi).It has been reported that expression of glucose transporter member 3 (GLUT3) is up-regulated in
bladder cancers. However, the regulating mechanism remains unknown. Here, we assessed whether
microRNAs (miRNAs) regulate GLUT3 expression in bladder cancers. In our study, miR-195-5p was
identiﬁed to directly targeted GLUT3 30-untranslated region (UTR) in bladder cancer T24 cells. Small
interfering RNA (siRNA)- and miR-195-5p-mediated GLUT3 knockdown experiments revealed that
miR-195-5p decreased T24 cells glucose uptake, inhibited cell growth and promoted cell apoptosis
through suppression of GLUT3 expression. Therefore, miR-195-5p is a novel and also the ﬁrst iden-
tiﬁed miRNA that targets GLUT3, and the aberrant decreased expression of miR-195-5p and conse-
quent GLUT3 up-regulation may contribute to bladder carcinogenesis.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction has a high afﬁnity for glucose, is reported to be up-regulated in sam-Bladder cancer is one of the common urological malignancies
occurring worldwide in both sexes. Patients with advanced bladder
cancer face 5-year survival rates of approximately 20–40% [1–3]
which have not changed over the last 20 years in spite of technolog-
ical advances. Many factors, such as genetic and epigenetic altera-
tions, contribute to activation of oncogenes and inactivation of
tumor suppressor genes in cancer cells, leading to tumorigenesis
and progression of bladder cancer [4]. More and more studies
indicate that accelerated glycolysis is one of themost important bio-
chemical characteristics of cancer cells [5]. Glucose transporter
(GLUT) proteins, also called solute carrier family 2 (SLC2), allow
the energy independent transport of glucose across the hydrophobic
cell membrane, down its concentration gradient, which is the ﬁrst
rate-limiting step for sugar metabolism in cells [6]. GLUTs are there-
fore important regulators of glucose metabolism in transformed
cells. Among 14 members of GLUTs, GLUT member 3 (GLUT3), whichchemical Societies. Published by E
lute carrier family 2; GLUT3,
helial cells; UTR, untranslated
iRNA, small interfering RNA;
snRNA, small nucleolar RNA;
ion; DG, deoxyglucose; PBS,
zol-2-yl)-2,5-diphenyl tetra-
inical Genetics, the Afﬁliated
anhao Street, Heping District,ples from patients with bladder cancer [7]. However, the GLUT3 up-
regulated mechanism in bladder cancer remains illusive.
MicroRNAs (miRNAs) are endogenous, non-coding RNA of about
22 nucleotides that regulates gene expression by controlling target
mRNA translation or degradation [8]. Approximate 1000 miRNAs
have been identiﬁed in the human genome (http://www.mirbase.
org/). Emerging evidences suggest that deregulated miRNAs are in-
volved in the pathogenesis of bladder cancer [9–11]. However, to
date, there have been no reports on miRNA that can regulate GLUT3
expression.
In the initial step of this study, we performedWestern Blot anal-
ysis of the GLUT3 protein in human bladder cancer T24 cell lines,
and found that GLUT3 expression was obviously up-regulated in
T24 cells compared with that in normal human urothelial cells
(HUC), which is consistent with GLUT3 expression in bladder cancer
tissues [7]. The aim of our study is to ﬁndmiRNAs that target GLUT3
expression in bladder cancer. We found that miR-195-5p inhibited
GLUT3 expression by targeting 30-UTR, and then performed func-
tional analyses of miR-195-5p in bladder cancer cells to investigate
its role in regulating glucose transport and cell proliferation.
2. Materials and methods
2.1. Cell culture
The human urinary transitional cell carcinoma cell lines T24
were cultured in RPMI 1640 medium supplemented with 10%lsevier B.V. All rights reserved.
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tured in Urothelial Cell Medium supplemented with urothelial cell
growth supplement and penicillin/streptomycin solution accord-
ing to manufacturer’s protocol. The cells were all cultured at
37 C in a humidiﬁed atmosphere containing 5% CO2.
2.2. Plasmid construction
GLUT3 30-untranslated region (30-UTR) containing putative
binding sites for miR-195-5p was ampliﬁed from normal human
genome DNA (primers sense, 50-GGACTAGTGTCGTGCCTCCTTC-
CACCT-30 and reverse, 50-CCCAAGCTTCTCCAGCATCAAATCTTC-
TACT-30), and cloned into the Spe I and Hind III sites of pMIR-
REPORT ﬁreﬂy luciferase (FFL) vector (Promega), named as
GLUT3-Wt. GLUT3mutant 30-UTR recombinant plasmid was gener-
ated by Site-directed Gene Mutagenesis Kit (Beyotime) with the
primers 50-CAGGACGCTTCTGAAGTGTCACTCTTAATTCCTTTCTC-30
and 50-GAGAAAGGAATTAAGAGTGACACTTCAGAAGCGTCCTG-30,
which generated a mutation of 7 bps from TGCTGCTA to GTGTCACT
in the predicted miR-195-5p target binding site, named as GLUT3-
Mut. All constructs were conﬁrmed by DNA sequencing.
2.3. Transfection
1.5  105 or 1  104/well T24 cells were seeded in 24-well
plates, 60 mm plates or 96-well plates, respectively, and incubated
overnight, then transfected with 50 nM miRNA precursor molecule
hsa-miR-195-5p (Ambion) or scrambled sequence pre-miR nega-
tive control (pre-miR-NC, Ambion) or small interfering RNA (siR-
NA) targeting GLUT3 (Santa Cruz) using Lipofectamine 2000
(Invitrogen).
2.4. Western blot
Cells were lysed and protein was harvested using PIPA buffer
(Beyotime). Total protein levels were determined by bicinchoninic
acid (BCA) analysis (Beyotime). Equal amount of the extracts were
subjected to SDS–PAGE, transferred onto nitrocellulose mem-
branes, and then protein was detected using primary antibodies
speciﬁc to GLUT3 (Santa Cruz) or GAPDH (ProteinTech), and horse-
radish peroxidase (HRP)-conjugated secondary antibodies (Zhong
Shan) with ECL regent (GE Bioscience).
2.5. TaqMan qRT-PCR for miRNA quantiﬁcation
Total RNA was isolated from cells with TRIzol (Invitrogen) and
treated by TURBO DNA-freeTM Kit (Ambion). Reverse transcription
was performed using TaqMan miRNA reverse transcription kit (Ap-
plied Biosystems) and small RNA-speciﬁc primers of miR-195-5p
or small nucleolar RNA (snRNA) U6 (control) (Applied Biosystems).
Real-time quantitative polymerase chain reaction (qPCR) was car-
ried out to measure the expression of mature miR-195-5p and U6
using Universal PCR Master Mix Kit (Applied Biosystems) and spe-
ciﬁc TaqMan probe (Applied Biosystems) following manufacture’s
instructions. The relative expression level of miR-195-5p was nor-
malized to U6 RNA by 2DDCT methods [12].
2.6. 30-UTR luciferase reporter assay
For reporter assay, T24 cells were cultured in 24-well plates and
transfected with 100 ng GLUT3-Wt or GLUT3-Mut together with
50 ng pRL-TK-Renilla-luciferase plasmid and 50 nM pre-miR-195-
5p or pre-miR-NC. Forty-eight hours later, luciferase activities
were measured using Dual Luciferase Reporter Assay System (Pro-
mega) according to manufacturer’s instructions. Fireﬂy luciferase
activity was normalized to renilla luciferase activity.2.7. [3H]-2-deoxyglucose ([3H]-2-DG) uptake experiment
For glucose uptake experiment, cells were plated in 24-well
plates at a density of 1.5  105 cells/well 2 days prior the uptake
experiment. Cells were washed with phosphate-buffered saline
(PBS), and uptake was initiated by 0.5 ml of incubation buffer
(15 mM Hepes pH 7.4, 135 mM NaCl, 5 mM KCl, 1.8 mM CaCl2,
0.8 mM MgCl2) containing 1 lCi of [3H]-2-DG (Dupont NEN) for
20 min at 37 C. Uptake was halted by washing cells with ice-cold
incubation buffer. Cells were dissolved in 200 ll of lysis buffer
(10 mM Tris–HCl, pH 8.0, 0.2% SDS) and the incorporated radioac-
tivity was measured by liquid scintillation spectrometry. Non-spe-
ciﬁc uptake was determined in the presence of cytochalasin B
(10 lmol/l) and was subtracted from all values.
2.8. Cell viability assay
The in vitro cell viability was determined by 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.
1  104/well T24 cells were seeded into 96-well culture plates. In
the indicated time points, 20 ll of 5 mg/ml MTT (Sigma) was added
to the media for 4 h incubation at 37 C. Following removal of the
culture medium, the remaining crystals were dissolved in 200 ll
DMSO (Sigma) and absorbance at 490 nm was measured.
2.9. Colony-forming assay
T24 cells were collected and dispersed into a suspension of sin-
gle cells in growth medium. One thousand cells were resuspended
in 2 ml growth medium containing 0.5% low melting temperature
agarose (Promega) and were overlaid on 2 ml solidiﬁed 0.5% low
melting temperature agarose in 6-well plates. The number of colo-
nies that had formed in the soft agar was counted after two weeks.
2.10. Flow cytometric analysis
Apoptosis was analyzed by ﬂow cytometry using an Annexin V
(AV)-FITC/Propidium Iodide (PI) apoptosis detection kit (4A Bio-
tech Co. Ltd.) according to manufacturer’s instruction. Cells were
harvested, washed, trypsinized and centrifuged. Then, 1  106 cells
were resuspended with 250 ll of Binding Buffer containing AV-
FITC (1:20) and 500 ng of PI for 15 min at 25 C in the dark. Sam-
ples were then analyzed using Becton-Dickinson ﬂow cytometer.
2.11. Statistics
Data are shown as mean ± S.E. Statistical signiﬁcance was deter-
mined by Student’s t-test, with P-value of <0.05 considered to be
statistically signiﬁcant.3. Results
3.1. Over-expression of GLUT3 protein in T24 cells
First, we detected the levels of GLUT3 protein in normal urothelial
HUC cells and bladder cancer T24 cells by Western blot analysis. As
shown in Fig. 1, only trace expression of GLUT3was seen in HUC cells,
while, GLUT3 expression wasmarkedly increased in T24 cells, indicat-
ing that GLUT3 protein is signiﬁcantly up-regulated in T24 cells.3.2. GLUT3 30-UTR is a predicted target of miRNA-195-5p
In order to ﬁnd miRNAs that regulate GLUT3 expression in blad-
der cancer, we performed computational analyses usingmiRNA tar-
get predication databases including PicTar,miRanda, DIANA-microT
Fig. 1. Expression levels of GLUT3 protein in normal urothelial HUC cells and
bladder cancer T24 cells. GLUT3 was signiﬁcantly up-regulated in T24 cells
compared with its expression level in HUC cells. GAPDH expression was used as a
protein loading control.
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dicted in all the four databases, none of the predicted miRNAs are
known to be down-regulated in bladder cancer [10,11]. miR-195-
5p has one predictive target site in theGLUT330-UTR (Fig. 2A), which
is highly conserved in 15 species. We also examined the expression
level of mature miR-195-5p in T24 cells by TaqMan qRT-PCR. As
shown in Fig. 2B, the expression of miR-195-5p was strikingly
down-regulated in T24 cells compared with that in HUC cells, sug-
gesting an inverse correlation between miR-195-5p and GLUT3
expression in T24 cells. Therefore, we selected miR-195-5p for fur-
ther studies to analyze the role of GLUT3 in bladder cancer.
3.3. GLUT3 is a direct target of miR-195-5p
To validate the computational predicted result, we examined
whether or not miR-195-5p can inhibit the expression level of
the endogenous GLUT3 protein in T24 cells. As expected, trans-
fection of pre-miR-195-5p into T24 cells resulted in substantially
increase of miR-195-5p expression compared to pre-miR-NC-
transfected cells (Fig. 3A). Over-expression of the miR-195-5p,
as well as GLUT3 knockdown by GLUT3 siRNA markedly reduced
the endogenous GLUT3 protein levels of T24 cells (Fig. 3B). Addi-
tionally, to conﬁrm that GLUT3 is a direct target of miR-195-5p,
we carried out luciferase reporter assays with vectors containing
the wild or mutant GLUT3 30-UTR as to the putative miR-195-5p
target sites (Supplementary Figure). As shown in Fig. 3C, co-
transfection of GLUT3-Wt with pre-miR-195-5p resulted in a sig-
niﬁcant decrease (57%) in luciferase protein levels; however,Fig. 2. miR-195-5p is predicted to target GLUT3 30-UTR in bladder cancer. (A) Schematic
binding site of miR-195-5p is indicated in the 96–102 of the GLUT3 30-UTR. The ﬁrst nuc
195-5p in HUC and T24 cells. The amounts of miR-195-5p were evaluated by performing
of miR-195-5p in T24 cells was compared to that in HUC cells. ⁄P < 0.01.mutation of the miR-195-5p binding site from the GLUT3 30-
UTR abolished this effect of miR-195-5p. These data demonstrate
that miR-195-5p directly inhibits GLUT3 expression by targeting
GLUT3 30-UTR.
3.4. miR-195-5p decreases glucose uptake of T24 cells
Given the well-established role of GLUT3 in glucose transport,
a putative effect of miR-195-5p on glucose usage was examined
using [3H]-2-DG uptake experiments. As shown in Fig. 4, the glu-
cose uptake capacity of T24 cells was signiﬁcantly higher than
that of HUC cells, indicating that glucose usage is accelerated
in bladder cancer cells than normal bladder cells. Meanwhile,
T24 cells expressing miR-195-5p and GLUT3 siRNA showed 41%
and 50% decrease in the uptake of [3H]-2-DG, respectively, com-
pared to pre-miR-NC-transfected cells. Therefore, miR-195-5p
may decrease glucose uptake of bladder cancer cells by down-
regulating GLUT3.
3.5. miR-195-5p suppresses proliferation and promotes apoptosis
in vitro
We next evaluated the effect of miR-195-5p on tumor cell
growth. We initially examined the proliferation rates of T24 cells
transient transfected with pre-miR-195-5p. As shown in Fig. 5A,
the pre-miR-195-5p- and GLUT3 siRNA-transfected cells exhibited
signiﬁcant growth suppression compared with the NC-transfected
or the untreated T24 cells (P < 0.05 at 48 h, and P < 0.01 at 72 and
96 h). Moreover, exogenous miR-195-5p over-expression as well as
GLUT3 siRNA transfection also signiﬁcantly promoted the apoptosis
of T24 cells compared with the control cells at 48 h after transfec-
tion (Fig. 5B). These results suggested that miR-195-5p-mediated
growth inhibition and cell apoptosis may occur in a GLUT3-depen-
dent manner in T24 cells.
To determine the role of miR-195-5p in bladder tumorigenesis,
we next carried out soft agar colony formation assays of T24 cells
after pre-miR-195-5p transfection. As shown in Fig. 5C, the pre-
miR-195-5p- and GLUT3 siRNA-transfected cells formed less
colonies than the NC-transfected cells in soft agar at two weeksdiagram of predicted target site of miR-195-5p in the GLUT3 30-UTR. The predicted
leotide after the stop codon of GLUT3 is deﬁned as ‘‘1’’. (B) Expression levels of miR-
the TaqMan qRT-PCR assay, and was normalized to U6 snRNA. The expression level
Fig. 3. miR-195-5p inhibits GLUT3 expression by targeting GLUT3 30-UTR. (A) Over-expression of mature miR-195-5p in pre-miR-195-5p (195-5p)-transfected T24 cells
determined by TaqMan qRT-PCR. (B) Western blot analysis of GLUT3 protein expression after transfection of pre-miR-NC (NC) or GLUT3 siRNA (siR) or pre-miR-195-5p in T24
cells. (C) Dual luciferase assay with co-transfection of the reporter vectors containing the wild type GLUT3 30-UTR (Wt) or mutant type GLUT3 30-UTR (Mut), and pre-miR-NC
or pre-miR-195-5p in T24 cells. ⁄P < 0.01.
Fig. 4. miR-195-5p decreases glucose uptake in T24 cells. Uptake of [3H]-2-DG by
untreated T24 and HUC cells, as well as T24 cells expressing GLUT3 siRNA and miR-
195-5p was normalized to pre-miR-NC-transfected T24 cells. Data are the means of
three independent experiments performed in triplicate. ⁄P < 0.01.
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tumorigenicity of bladder cancer cells through suppression of
GLUT3 expression.
4. Discussion
It is well known that the most fundamental metabolism alter-
nation in tumor cells is increased levels of glucose uptake and gly-
colysis. Our study data indicates that glucose transportation in
bladder cancer cells is obviously increased. Importantly, we dem-
onstrate for the ﬁrst time that miR-195-5p over-expression has a
negative effect on bladder cancer T24 cell glucose uptake and cell
growth by decreasing GLUT3 protein expression. In T24 cells,
miR-195-5p expression was inversely correlated with GLUT3
expression, moreover, miR-195-5p directly reduced GLUT3 protein
levels, indicating that aberrant miR-195-5p expression may be a
novel mechanism underlying GLUT3 up-regulation in bladder can-
cer. Additionally, miR-195-5p over-expression and knockdown of
GLUT3 by siRNA decreased T24 cells glucose uptake, inhibited cell
growth and promoted cell apoptosis. These ﬁndings suggest that
miR-195-5p may be a tumor suppressor that controls GLUT3
expression in bladder cancer cells.
Literature review indicates that GLUT3 is also overexpressed in
many other cancer types, including glioma [13], oral squamous cell
cancer [14], cervical cancer [15] and gallbladder cancer [16]. The
level of GLUT3 in normal bladder urothelial cells is extremely
low, while, in bladder cancer T24 cells, decreased miR-195-5p
expression contributes to high GLUT3 expression, thus, may main-
tain transport of glucose at a high rate to ensure tumor cells sur-
vival and growth. Furthermore, our study validated previously
reported results that increased glucose uptake caused by GLUT3
can further promote cell proliferation and reduce cell apoptosis
[17–19], which contributes to tumorigenesis. Till now, besidesGLUT3, GLUT1 has also been reported to be positively associated
with bladder cancer [20–22]. However, compared with other GLUT
members, GLUT3 has both a higher afﬁnity for glucose and greater
transport capacity [23–26], suggesting that GLUT3 may play a very
important role in sugar metabolism.
On the other hand, as the ﬁrst identiﬁed miRNA of GLUT3 pro-
tein, miR-195-5p is suggested to function as a tumor suppressor
in bladder cancer development, which is consistent with its roles
in hepatocellular carcinoma [27], adrenocortical carcinoma
[28,29], colorectal cancer [30] and breast cancer [31]. However,
miR-195-5p expression is reported to be elevated in chronic lym-
phocytic leukemia [32]. Hence, the roles of miR-195-5p may be dif-
ferent in different types of cancers. Additionally, the underlying
mechanisms mediating miR-195-5p deregulation in cancer
Fig. 5. miR-195-5p reduces cell proliferation and promotes cell apoptosis in vitro. (A) In vitro cell proliferation assays after GLUT3 knockdown by pre-miR-195-5p or siRNA in
T24 cells. The control cells were transfected with NC or untreated. (B) T24 cells were transfected as (A). After 48 h, cell apoptosis was detected. Cell death is monitored by AV-
FITC/PI staining and ﬂow cytometry. The right lower quadrant of each plot contains early apoptotic cells, whereas the right upper quadrant contains late apoptotic cells. (C)
The number of colonies formed in soft agar by T24 cells transfected as (A) was counted, and normalized to that of pre-miR-NC-transfected cells. Data are the mean ± S.E. from
three independent experiments. ⁄P < 0.01.
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miR-195-5p expression in cancer is mediated by epigenetic altera-
tions remains to be further investigated.
In conclusion, for the ﬁrst time, we demonstrated that miR-195-
5p is a novel tumor suppressor miRNA, which targets GLUT3, may
contribute to bladder carcinogenesis. Meanwhile, miR-195-5p is
also the ﬁrst identiﬁed miRNA to regulate GLUT3 expression. These
ﬁndings have important implications for explaining the increased
GLUT3 levels and glucose uptake in bladder cancer. Of course, it
is probable that other regulators of GLUT3 may also participate in
bladder cancer development and accelerating glycolysis. Taken to-
gether, our ﬁndings may lead to new diagnostic and therapeutic
approaches for bladder cancer, and provide new insights into the
posttranscriptional regulation of GLUT3.
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